Cargando…
Survivin Inhibition Is Critical for Bcl-2 Inhibitor-Induced Apoptosis in Hepatocellular Carcinoma Cells
Our study aims to study the therapeutic effects of a novel Bcl-2 inhibitor, ABT-263, on hepatocellular carcinoma (HCC) and to provide primary preclinical data for future clinical trial with ABT-263. In this study we showed that Bcl-xL and survivin were up-regulated in HCC cell lines and human liver...
Autores principales: | Zhao, Xiangxuan, Ogunwobi, Olorunseun O., Liu, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148218/ https://www.ncbi.nlm.nih.gov/pubmed/21829603 http://dx.doi.org/10.1371/journal.pone.0021980 |
Ejemplares similares
-
Epigenetic Upregulation of HGF and c-Met Drives Metastasis in Hepatocellular Carcinoma
por: Ogunwobi, Olorunseun O., et al.
Publicado: (2013) -
Mechanisms of hepatocellular carcinoma progression
por: Ogunwobi, Olorunseun O, et al.
Publicado: (2019) -
Targeting PVT1 Exon 9 Re-Expresses Claudin 4 Protein and Inhibits Migration by Claudin—Low Triple Negative Breast Cancer Cells
por: Levine, Fayola, et al.
Publicado: (2021) -
Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study
por: Beales, Ian LP, et al.
Publicado: (2007) -
Emergence of neural regulatory mechanisms in carcinogenesis
por: Harricharran, Trisheena, et al.
Publicado: (2019)